Standout Papers

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approa... 2014 2026 2018 2022 1.7k
  1. Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade (2014)
    Philip J. Johnson, Sarah Berhane et al. Journal of Clinical Oncology
  2. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial (2017)
    Tim Meyer, Richard Fox et al. ˜The œLancet. Gastroenterology & hepatology

Immediate Impact

2 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
8 intermediate papers

Works of Richard Fox being referenced

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Richard Fox 1553 2263 778 49 3.6k
Jehad Almasri 774 920 620 40 2.6k
M. A. van Leeuwen 466 286 595 39 9.8k
Jorge Sánchez‐Guerrero 387 460 469 86 6.8k
Henrik Källberg 561 220 305 65 5.6k
M Kadoya 1468 1904 870 108 3.5k
Daniel J. Nolan 1134 835 2014 111 7.3k
L.B.A. van de Putte 512 250 496 79 9.6k
Daniël C. Aronson 576 2072 3404 144 6.1k
Dominique Ibañez 412 304 376 79 6.5k
Stefano Bombardieri 504 570 676 85 3.2k

All Works

Loading papers...

Rankless by CCL
2026